Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Community Involvement in the Centre

Community Involvement and Consumer Representatives are a really important part of our research. Find out what they have been working on.

News & Events

Researcher Spotlight - David Bloom

David Bloom is a Professor of Economics and Demography at Harvard Chan School of Public Health, Global Health and Population and a Principal Investigator for our JDRF Global Centre of Excellence

News & Events

Congratulations 2024 Seed Funding Recipients!

The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence announces $60,000 in new round of seed grants for researchers dedicated to type 1 diabetes. Three researchers from across Australia have received up to $20,000 to advance their research projects in type 1 diabetes (T1D). 

News & Events

Research roundup

Our researchers have been busy. Here's a look at some of their work to be published recently.

Research

Do carer’s levels of unmet needs change over time when caring for patients diagnosed with high-grade glioma and how are these needs correlated with distress?

The aim of the current study was to determine how carer needs changed longitudinally and understand associations between unmet needs and distress.

Research

Widespread haemorrhages in infants post-shunting (WHIPS): clinical features, risk factors and neuroimaging characteristics of a rare and under-recognised phenomenon

Infants undergoing CSF shunting procedures face a rare complication which we propose to rename "Widespread Haemorrhages in Infants Post-Shunting" (WHIPS) to better capture this unique phenomenon specific to infants undergoing CSF diversion. Our objective is to analyse the risk factors for WHIPS development and provide a detailed neuroradiological description of these haemorrhages.

Research

Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting

The Platform trial In COVID-19 priming and BOOsting (PICOBOO) is a multi-site, adaptive platform trial designed to generate evidence of the immunogenicity, reactogenicity, and cross-protection of different booster vaccination strategies against severe acute respiratory syndrome coronavirus 2 and its variants, specific for the Australian context.